Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege.

Abstract excerpt

Allogeneic mesenchymal stem cell (MSC) transplantation improves cardiac function, but cellular differentiation results in loss of immunoprivilege and rejection. To explore the mechanism involved in this immune rejection, we investigated the influence of interleukin-6 (IL-6), a factor secreted by MSCs, on immune privilege after myogenic, endothelial and smooth muscle cell differentiation induced by 5-azacytidine,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Death
• Share to Cytotoxicity, Immunologic